Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04511806 · ClinicalTrials.gov registry record
Childhood Cancer Predisposition Study (CCPS)
A clinical trial of Pediatric Cancer, sponsored by Emory University.
- Recruiting
- Registry status
- 1,050
- Enrollment target
- 7
- Study locations
NCT04511806: Recruiting study of Pediatric Cancer, sponsored by Emory University.
NCT04511806 is a study of Pediatric Cancer that is actively recruiting participants, run by Emory University. The registered enrollment target is 1,050 participants, below the 1,470-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (29% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04511806, a study of Pediatric Cancer, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- 1,050 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Primary Outcome
This multicenter registry and biorepository will be developed with the purpose of studying individuals at high risk for childhood cancer to improve care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Conditions Studied
Interventions
- OTHER Registry
Study Locations (7)
Georgia
- Children's Healthcare of Atlanta (CHOA) - Atlanta
Massachusetts
- Dana Farber Cancer Institute - Boston
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- St. Jude Children's Research Hospital - Memphis
Texas
- Baylor College of Medicine - Houston
Utah
- Primary Children's Hospital - Salt Lake City
Ontario
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2030-10 |
What NCT04511806 shows while recruiting
NCT04511806 is an observational study that tracks outcomes without assigning an intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, below the 1,470-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.
NCT04511806 lists 7 locations in 7 states (Georgia, Massachusetts, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT04511806 about?
NCT04511806 is a clinical study titled "Childhood Cancer Predisposition Study (CCPS)". The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h...
What is the current status of trial NCT04511806?
This trial is currently recruiting. The enrollment target is 1,050 participants. The study started on 2021-04-22. Estimated completion is 2030-10.
What conditions does trial NCT04511806 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT04511806?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT04511806?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04511806 being conducted?
This trial has 7 study locations across Georgia, Massachusetts, Pennsylvania, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04511806's enrollment target sits among peer trials
1,050 4th of 51 higher than 48 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LIFE Cancer Survivorship Database for Pediatric Cancer
RECRUITING
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
RECRUITING
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
RECRUITING · Phase 1
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
- NCT05958342 · 1,050 participants · Phase 2
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI